517 related articles for article (PubMed ID: 15867352)
1. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
[TBL] [Abstract][Full Text] [Related]
2. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter.
Cicek M; Fukuyama R; Cicek MS; Sizemore S; Welch DR; Sizemore N; Casey G
Clin Exp Metastasis; 2009; 26(3):229-37. PubMed ID: 19165610
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation.
Samant RS; Clark DW; Fillmore RA; Cicek M; Metge BJ; Chandramouli KH; Chambers AF; Casey G; Welch DR; Shevde LA
Mol Cancer; 2007 Jan; 6():6. PubMed ID: 17227585
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
Sliva D; English D; Lyons D; Lloyd FP
Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207
[TBL] [Abstract][Full Text] [Related]
5. BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells.
Sheng XJ; Zhou DM; Liu Q; Lou SY; Song QY; Zhou YQ
Eur J Gynaecol Oncol; 2014; 35(3):236-42. PubMed ID: 24984534
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
[TBL] [Abstract][Full Text] [Related]
7. Multiple pathways are involved in the anoxia response of SKIP3 including HuR-regulated RNA stability, NF-kappaB and ATF4.
Rzymski T; Paantjens A; Bod J; Harris AL
Oncogene; 2008 Jul; 27(33):4532-43. PubMed ID: 18408768
[TBL] [Abstract][Full Text] [Related]
8. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
[TBL] [Abstract][Full Text] [Related]
9. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
10. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.
Moreau M; Mourah S; Dosquet C
Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression.
Yang J; Zhang B; Lin Y; Yang Y; Liu X; Lu F
Cancer Lett; 2008 Sep; 269(1):46-56. PubMed ID: 18502034
[TBL] [Abstract][Full Text] [Related]
12. Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells.
Yang J; Richmond A
Cancer Res; 2001 Jun; 61(12):4901-9. PubMed ID: 11406569
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells.
Huang Y; Johnson KR; Norris JS; Fan W
Cancer Res; 2000 Aug; 60(16):4426-32. PubMed ID: 10969788
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
16. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
18. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
Zhang S; Lin QD; DI W
Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
[TBL] [Abstract][Full Text] [Related]
19. Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types.
Majumdar S; Aggarwal BB
Oncogene; 2003 Feb; 22(8):1206-18. PubMed ID: 12606947
[TBL] [Abstract][Full Text] [Related]
20. Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB.
Andela VB; Schwarz EM; Puzas JE; O'Keefe RJ; Rosier RN
Cancer Res; 2000 Dec; 60(23):6557-62. PubMed ID: 11118032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]